Drug Week articles from September 2001

Drug Week archives from September 2001

Staph. aureus Is Expert At Acquiring Drug-Resistance.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- One of the most widely disseminated strains of an antibiotic-resistant bacterium responsible for hundreds of infections in European hospitals can be traced back to the 1950s, according to...

Herb Used To Treat Migraine Headaches Could Be Used To Create New Anti-Inflammatories.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Yale University researchers have shown for the first time that a component of the medicinal herb feverfew targets a protein called IkappaB Kinase and halts that protein's role in the inflammation...

Effective Treatments Lacking For Most Desperate Patients.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- New medications are urgently needed for individuals who have drug-resistant HIV, and academia, industry, and government must work together to bring them into the clinic, urged AIDS researchers in an...

Medical School Leaders Give U.S. Enterprises Low Marks.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- For years, the medical community has warned of an impending crisis in clinical research. A study released in the August 15, 2001, Journal of the American Medical Association says that close to half...

Investigational Drugs Inconclusive In Slowing Progression.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- A large-scale clinical trial that tested the ability of the investigational drugs remacemide and Coenzyme Q10 to slow the progression of Huntington disease showed that neither drug resulted in any...

Comparison Study Finds No Difference Between Two Antirejection Drugs.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- One of the latest drugs designed to keep the body's immune system from attacking a life-saving organ transplant works no better than a 40-year-old mainstay in warding off short-lived bouts of...

Combination Therapy Overcomes Drug Resistance.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Miami School of Medicine observed that arsenic trioxide in combination with ascorbic acid may overcome or circumvent the major resistance mechanisms found in...

ADHD And Tic Disorders In Children Corrected With Guanfacine.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Children with attention deficit hyperactivity disorder (ADHD) and tic disorders showed a 37% improvement when they took the medication guanfacine, an alternative to drugs like Ritalin, which can...

Antibody Halts Infection.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Scientists working at The Scripps Research Institute (TSRI) and at the University of California, San Francisco, have published a paper in the journal Nature describing an antibody that clears prion...

Quinacrine And Chlorpromazine Effective Against Infectious Protein In Mouse Studies.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- University of California, San Francisco, researchers have determined that two drugs currently approved to treat either malaria or certain psychotic illnesses are effective in treating mouse cells...

Improved Lipoprotein Profile In Patients Taking Nevirapine.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Preliminary findings from three studies presented at the First International AIDS Society Conference on HIV Pathogenesis and Treatment, July 2001, demonstrate that HIV positive individuals taking a...

Pill Touted As Cure Is Useless, Declares Thai Government.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- A pill that was distributed free by a private foundation to thousands of people as an AIDS cure appears to be useless, the Public Health Ministry of Thailand has said. The Salang Bunnag...

Ziagen/Combivir Regimen Results In Superior Efficacy.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Shire Pharmaceuticals Group plc (SHPGY) announced results of a long-term study in which a Ziagen(R)/Combivir(R) regimen compared favorably with an indinavir/Combivir regimen in terms of patient...

Association Issues Statement On Experimental Drug AN-1792.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- The Alzheimer's Association welcomes the news that the experimental plaque-clearing drug AN-1792 appears to be well tolerated for human use, elicits an immune response in some patients, and is ready...

Secretin Improves Symptoms In Pediatric Population.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Results from a Phase II clinical trial of secretin showed a significant treatment effect in children treated for autism, and an even better clinical response in the subgroup of children with normal...

Phase II Clinical Trial Of Enzyme Inhibitor Initiated.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Vion Pharmaceuticals, Inc. (VION) has initiated a Phase II clinical trial of its anticancer agent Triapine(R) for patients with metastatic breast cancer. The study will be conducted at the...

Clarithromycin Extended-Release Tablet Receives FDA Approval.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories announced that it has received U.S. Food and Drug Administration (FDA) approval of a new seven-day indication for Biaxin(R) XL (clarithromycin extended-release tablets) for the...

FDA Approves New Treatment.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved Natrecor(R) (nesiritide) Injection for the treatment of acute congestive heart failure (CHF). Natrecor is a synthetic version of a human...

Purine Derivative Activates Neurotrophic Factors.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- NeoTherapeutics, Inc. (NEOT) announced that it has been granted a U.S. patent covering the use of purine derivatives, such as Neotrofin(TM), to selectively activate or depress genes encoding for...

One Third Of Seniors Take Medications Prescribed By Two Or More Physicians.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- New research reveals that one third (34%) of seniors are taking medications prescribed by two or more physicians and that seven out of ten (72%) seniors reported taking medications that were first...

Bayer Anticholesterol Drug May Be Linked To 52 Deaths.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Bayer AG said on August 13, 2001, that its Baycol anticholesterol drug may be linked to 52 deaths, five days after Germany's biggest drug maker announced a voluntary recall of the drug. The...

Novel Immunosuppressant Now Comes In Tablet Formulation.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Wyeth-Ayerst Laboratories announced that the first solid formulation of its transplant immunosuppressant, Rapamune(R) (sirolimus), is now available in the United States. The new 1-mg tablet...

Botanically Derived Drug Begins Phase II Trial.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Preliminary findings of research currently being conducted in the U.S. indicate that a drug derived from a Chinese herb and administered in capsule form significantly improves the efficacy of...

Favorable Preclinical Results Reported For Carbohydrate Aerosol.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Following positive results of toxicology testing, BCY LifeSciences Inc. announced that it is planning to begin clinical testing in Canada of an aerosol mist form of its investigational drug...

Milestone Reached In Phase I Enzyme Replacement Therapy Study.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc. (BMRN) announced that it has completed the 24-week treatment stage of its Phase I clinical trial of recombinant human N-acetylgalactosamine 4-sulfatase (rhASB), an...

Positive Phase II Trial Outcomes With Mucoadhesive Liquid Technology.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc. (AKC) announced results from its Phase II randomized clinical study of OraRinse(TM) for the prevention and treatment of mucositis, or inflammation of the mucosal...

Oral Parathyroid Hormone Has Promising Preclinical Results.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Emisphere Technologies, Inc. (EMIS), announced that an oral delivery formulation of its parathyroid hormone (PTH) fragment produces serum PTH levels comparable to those found following injection in...

States Seek To Bring Down Drug Costs.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Bedeviled by sharply rising prescription drug costs, states across the U.S. are seeking new strategies for wringing discounts from pharmaceutical companies. At the same time, the states are...

Ophthalmic Drug Verteporfin Effective When Activated By LED.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- QLT and Novartis Ophthalmics join in the battle against a rare genetic skin cancer by announcing that the drug verteporfin, marketed for the treatment of age-related degenerative eye disease, has...

New Antirejection Drug Enters Phase II Trials.
September 7, 2001... 2001 SEP 7 - (NewsRx.com & NewsRx.net) -- Isotechnika announced that the first kidney transplant patient has been enrolled in Phase II trials of the novel immunosuppressive drug ISA(TX)247. Within the next few months, 120 patients at...

'Imprinted' Gels Hold Promise For Future Medical Devices.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Scientists at Purdue University are creating a biological sensor for glucose in research that ultimately may help to design "intelligent" drug delivery devices that could be implanted in the body...

New Drug Succeeds In First Animal Tests.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Researchers at The Johns Hopkins University have designed a new drug for malaria that has easily passed the first stage of preclinical testing in mice and rats. Scientists announced their...

Popular Anti-Inflammatory Drugs May Increase Risk Of Cardiovascular Events.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- An analysis of clinical trials suggests a potential increase in the rate of heart attack, stroke, and other cardiovascular events among patients treated with the popular anti-inflammatory drugs...

New Chemistry Being Developed For Delivery Of Neuroprotective Drugs.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- One approach to treating neurodegenerative disease such as Parkinson disease is to interfere with the chemistry involved. Thus, scientists study the brain's chemical pathways and try to identify...

Researchers Closer To Delivering New Insulin Pill For Diabetics.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Chemical engineers are getting closer to developing a method for taking insulin and other medications orally instead of by injection - research that would benefit hundreds of thousands of diabetics...

Scientists Develop New Way To Calculate Stability Of Proteins.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Scientists at the University of North Carolina schools of medicine and pharmacy have teamed up to develop a new way to calculate the stability of cellular proteins. The collaboration has...

Substitution Of Generic Drugs May Cause Problems For Patients.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- A new study adds weight to the argument that, for some epilepsy medications, generic drugs should not be substituted for brand-name drugs, at least not without informing the patient and physician....

New Combination Therapy Could Reduce Ischemia After Heart Attack.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- The treatment of acute heart attack requires combination of several therapies. But fibrinolytic agents given together with aspirin and unfractionated heparin often fail to restore coronary artery...

Caveolae Serve As Door To Cells For Pathogens And Toxins.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Microbiologists at Duke University Medical Center show from a review of studies that a puzzling depression in cells may serve as an invading pathway for pathogens such as HIV and other viruses and...

CURE Study Results Show Benefit Of Clopidogrel.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Results of the landmark CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events) study demonstrated that initiating therapy with clopidogrel early, and continuing its use long...

One-Year Studies Demonstrate Positive Outcomes From Use Of Donepezil HCl.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Results from two long-term trials with Aricept(R) (donepezil HCl) show that patients with mild to moderate Alzheimer disease maintain cognitive function and preserve function for daily activities...

Two Drug Candidates Receive Orphan Drug Status From FDA.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc. announced that Endostatin and Panzem(TM), two of its antiangiogenesis agents, have received orphan drug status from the U.S. Food and Drug Administration (FDA) based on promising...

Macrophage Migration Inhibitory Factor Is Novel Drug Target.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- AVANIR Pharmaceuticals (AVN) announced that it has acquired a macrophage migration inhibitory factor (MIF) technology from the Ciblex Corporation. The asset acquisition provides AVANIR with...

First Structural Insight Into New Class Of Protease Cancer Targets Presented.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Corvas International, Inc. (CVAS) reported that company scientists and collaborators at the Max-Planck Institute of Biochemistry in Martinsried, Germany, have solved the three-dimensional molecular...

Anhydrovinblastine Completes Phase I Safety Study.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Prescient NeuroPharma, Inc. (PRE) announced that it has successfully completed a Phase I clinical trial demonstrating the safety and tolerability of Anhydrovinblastine (AVLB). "The final...

Intravenous Nesiritide Receives FDA Approval.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Scios, Inc., announced that it has received final approval from the U.S. Food and Drug Administration (FDA) to market Natrecor(R) (nesiritide) for the intravenous treatment of patients with acutely...

Pravastatin Sodium Has An Impressive Safety Profile.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Pravachol (pravastatin sodium), which was approved by the U.S. Food and Drug Administration (FDA) in 1991, has been prescribed for more than 10 million patients and has been the subject of three...

Consumer Groups Ask FDA To Withdraw New Patent On Costly Heart Drug.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Thirty-four Stop Patient Abuse Now (SPAN) members, representing thousands of consumers and seniors, sent a petition to Tommy Thompson, the Secretary of Health and Human Services, Bernard Schwetz,...

Inhaled Nitric Oxide Therapy Approved For Critically Ill Newborns.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- INO Therapeutics announced that the European Commission has approved the use of INOmax(R) (nitric oxide) inhalation gas, a new treatment to help critically ill neonates breathe more effectively and...

Type 2 Diabetics Protected By Angiotensin II Receptor Antagonist.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Irbesartan, an angiotensin II receptor antagonist (AIIRA), helps prevent kidney disease in patients suffering from hypertension and type 2 diabetes. Bristol-Myers Squibb Company and...

Study To Test Whether Addition Of Maintenance Therapy Improves Survival.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- The Southwest Oncology Group (SWOG) has announced the start of a Phase III clinical trial to compare conventional chemoradiotherapy using consolidation docetaxel (Taxotere(R)) followed by...

First Peer-Reviewed Study Of Thalidomide Published Recently.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- The first peer-reviewed study evaluating the potential use of Thalomid (thalidomide) to treat myelodysplastic syndromes (MDS) was published recently. The study, titled "Thalidomide produces...

Phase IB Trial Of RK-0202 Initiated In Transplant Patients.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- RxKinetix, Inc. announced that it has initiated a Phase IB trial with its first lead drug candidate in bone marrow and stem cell transplant patients. The study, which is being conducted under...

Phase III Study Results For Transdermal Oxybutynin Patch Reported.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- In a large-scale, randomized, placebo-controlled clinical trial, patients treated with transdermal oxybutynin achieved statistically significant reductions in symptoms of overactive bladder, and an...

Contraceptive Safe And Effective Against HIV Transmission.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- In a recent paper, scientists at Parker Hughes Cancer Center reported that 5-bromo-6-methoxy-5,6,-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methyoxyalaninyl phosphate (WHI-07), a potent...

Drug Significantly Arrests Tumor Growth with Minimal Side Effects, Study Shows.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- A study published in the September 2001 issue of the Journal of Urology is the first of its kind to show a significant effect of a new class of drugs that may stabilize progressive, recurrent...

Treprostinil Sodium Recommended For Approval By FDA Committee.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- United Therapeutics announced that the Cardiovascular and Renal Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended, by a vote of six to three, approval of Remodulin...

Phase I Study Evaluates Novel Respiratory Nasal Spray.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Inspire Pharmaceuticals, Inc. announced that an investigational new drug application (IND) has been filed with the U.S. Food and Drug Administration for INS37217 respiratory nasal spray for the...

Combination Therapy Receives FDA Approval.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corporation announced that the U.S. Food and Drug Administration (FDA) has approved Peg-Intron (peginterferon alfa-2b) Powder for Injection for use in combination therapy with...

Formulation Demonstrates Extended Release In Phase I Study.
September 14, 2001... 2001 SEP 14 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc. and Alkermes, Inc. announced results from an initial safety study in healthy volunteers designed to investigate multiple long-acting release (LAR) formulations of...

Cyclin-Dependent Kinase Blockers Inhibit Viral Activity.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Drugs that interfere with the function of one class of cell-cycle blockers may represent a potent class of HIV inhibitors, researchers report. ...

Microbicide Shows Potential Against Herpes Simplex.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- by N.R. Saltmarsh, staff medical writer - A vaginal microbicide shows promise in preventing transmission of herpes simplex and possibly other sexually transmitted diseases, researchers in Canada...

Indinavir-Ritonavir Treatment May Cause Ingrown Toenails.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Delaware warn that severe cases of ingrown toenails have been observed in HIV patients treated with indinavir (IDV) and ritonavir (RTV). ...

Meloxicam Data Demonstrate No Increased Cardiovascular Risk.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Results from a pooled analysis of 35 clinical trials with 27,039 patients, of whom 15,071 were taking the nonsteroidal anti-inflammatory drug (NSAID) Mobic (meloxicam) at the recommended starting...

Researchers Test Drug That Inhibits New Blood Vessel Growth.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Researchers at Mayo Clinic in Jacksonville, Florida, are participating in a Phase III, metastatic breast cancer study of a novel drug shown to inhibit growth of new blood vessels. In previous...

FDA Approves New Medication For Acute Pain Relief.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved Ultracet (37.5 mg tramadol hydrochloride/325 mg acetaminophen tablets), a new centrally acting prescription pain medication. Ultracet...

Phase I/II Clinical Trial Of ANTICORT Completed.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Samaritan Pharmaceuticals, Inc. announced it has completed its Phase Ib/IIa, dose-escalating clinical human trial for safety, toxicity, and efficacy of Anticort in patients with HIV infection. ...

Company Recalls Children's Pain Reliever Suspension Liquid.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Perrigo Company announced that, in cooperation with the U.S. Food and Drug Administration (FDA), it is conducting a recall of 7,788 four-ounce bottles of cherry-flavored pain reliever suspension...

Treatment Boasts Money Back Guarantee.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Berlex Laboratories, Inc., announced a money back guarantee program for patients using its topical acne medicine, Finevin (azelaic acid cream) 20%, for the treatment of mild-to-moderate...

Phase I Study Of Topical Treatment Commences.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Photogen Technologies, Inc. announced the initiation of a Phase I human clinical study of its proprietary drug, PH-10, as a topical treatment for actinic keratosis - a potentially precancerous...

Chemically Advanced Form Of Ritalin Approved By FDA.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Novartis Pharmaceuticals Corporation and Celgene Corporation announced an approvable letter from the U.S. Food and Drug Administration (FDA) for dexmethylphenidate HCl. Dexmethylphenidate HCl...

New Research Reveals Important New Target For Drug Development.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- New research by Biogen scientists offers important insights into the mechanism and possible treatment of autoimmune diseases. The studies present new information about BAFF (B-cell activating...

First Clinical Trial Of Mucoregulator Therapy Initiated.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Genaera Corporation announced the initiation of its first clinical trial for testing its mucoregulator compound, Lomucin. This is the first test of a compound that takes a new approach to...

Peptide Drug Completes Promising Pilot Clinical Trial.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Chrysalis Biotechnology, Inc. announced that it has completed analysis of a pilot Phase I/II clinical trial in diabetic ulcers for its drug Chrysalin. This is the first clinical trial using...

Encapsulated Probiotics Are Protected Until Delivery.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Balchem Encapsulates and Institut Rosell announced a major breakthrough in the encapsulation of probiotics. This announcement comes after more than two years of collaboration between Balchem...

Clearer Labelling Should Benefit Patients/Professionals.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- A further boost to patient safety was announced by the United Kingdom Committee on Safety of Medicines (CSM) which set out proposals for the clearer labelling of drugs to benefit patients and...

Verteporfin Approved For Pathologic Myopia And Ocular Histoplasmosis.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Novartis Ophthalmics and QLT, Inc. (QLTI) announced that the United States Food and Drug Administration (FDA) has approved Visudyne (verteporfin for injection) therapy for the treatment of...

FDA Approves Zoledronic Acid Treatment.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Novartis has received marketing approval from the U.S. Food and Drug Administration (FDA) for Zometa (zoledronic acid for injection), a new generation intravenous (IV) bisphosphonate for the...

Enrollment In Phase III Trial Of Interferon Gamma-1b Completed.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- InterMune, Inc. announced that it has completed enrollment in its Phase III clinical trial evaluating the safety and efficacy of Actimmune (Interferon gamma-1b) for the treatment of idiopathic...

Phase I Trial Of OC-1012 Initiated In Cancer Patients.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- OraPharma, Inc. announced the start of a Phase I clinical trial of OC-1012 for the prevention of mucositis, following the U.S. Food and Drug Administration's (FDA) recent clearance of its...

Problems And Ambiguity Among Alternative Estrogen Products.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- ConsumerLab.com, an independent evaluator of dietary supplements and nutrition products, released results of its Phytoestrogen Product Review. The review focused on dietary supplements made...

Vegetarian-Based Gel Capsule Developed.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- An innovative range of food supplements made without gelatin was launched by a United Kingdom company, Brunel Healthcare, at the August ECRM Conference. Vertese is the first vegetable-based...

Sertraline HCl Approved For Long-Term Use.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Pfizer, Inc. announced that it has received U.S. Food and Drug Administration (FDA) approval for long-term use of Zoloft (sertraline HCl) in the treatment of post-traumatic stress disorder (PTSD)....

Preliminary Results Using Etanercept Are Positive.
September 21, 2001... 2001 SEP 21 - (NewsRx.com & NewsRx.net) -- Immunex Corporation announced positive preliminary results from its first clinical study of Enbrel (etanercept) in psoriasis patients. In this Phase II clinical study, 112 patients with...